Home/Filings/4/0001628908-24-000096
4//SEC Filing

Blackley Seth 4

Accession 0001628908-24-000096

CIK 0001628908other

Filed

Aug 25, 8:00 PM ET

Accepted

Aug 26, 8:13 PM ET

Size

16.8 KB

Accession

0001628908-24-000096

Insider Transaction Report

Form 4
Period: 2024-08-22
Blackley Seth
DirectorChief Executive Officer
Transactions
  • Sale

    Class A Common Stock

    2024-08-22$30.00/sh187,904$5,637,120411,924 total
  • Exercise/Conversion

    Class A Common Stock

    2024-08-22$6.87/sh+100,000$687,000511,924 total
  • Exercise/Conversion

    Class A Common Stock

    2024-08-22$10.27/sh+35,162$361,114547,086 total
  • Exercise/Conversion

    Class A Common Stock Option (right to buy)

    2024-08-22100,0000 total
    Exercise: $6.87Exp: 2025-02-01Class A Common Stock (100,000 underlying)
  • Exercise/Conversion

    Class A Common Stock Option (right to buy)

    2024-08-2252,7420 total
    Exercise: $10.27Exp: 2026-03-01Class A Common Stock (52,742 underlying)
  • Exercise/Conversion

    Class A Common Stock

    2024-08-22$10.27/sh+52,742$541,660599,828 total
  • Exercise/Conversion

    Class A Common Stock Option (right to buy)

    2024-08-2235,1620 total
    Exercise: $10.27Exp: 2026-03-01Class A Common Stock (35,162 underlying)
Footnotes (7)
  • [F1]The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 29, 2024.
  • [F2]Includes restricted stock units granted under awards reported on Table 1 of Form 4s previously filed with the Securities and Exchange Commission.
  • [F3]Since the date of the reporting person's last ownership report, Mr. Blackley transferred 348,458 shares of Evolent Health, Inc. Class A Common Stock pursuant to a domestic relations order. Mr. Blackley no longer reports as beneficially owned any securities owned by his ex-spouse.
  • [F4]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $30.00 to $30.02, inclusive. The reporting person undertakes to provide to Evolent Health, Inc., any security holder of Evolent Health, Inc., or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  • [F5]The Class A Common Stock Options exercised vested on February 1, 2019.
  • [F6]The Class A Common Stock Options exercised vested on March 1, 2019 and March 1, 2020.
  • [F7]The Class A Common Stock Options exercised vested on March 1, 2020.

Issuer

Evolent Health, Inc.

CIK 0001628908

Entity typeother

Related Parties

1
  • filerCIK 0001643346

Filing Metadata

Form type
4
Filed
Aug 25, 8:00 PM ET
Accepted
Aug 26, 8:13 PM ET
Size
16.8 KB